Nanofilm Technologies (MZH) H2 2023 earnings summary
Event summary combining transcript, slides, and related documents.
H2 2023 earnings summary
21 Oct, 2026Executive summary
FY2023 revenue was S$177.0m, down 25.4% YoY; 2H revenue reached S$103.9m, up 42% HoH and down 18% YoY.
2H recovery and cost optimisation supported S$10.8m PATMI and positive operating cash flow; FY2024 guidance targets higher revenue and profits, subject to no major unexpected events.
Financial highlights
FY2023 PATMI was S$3.1m, down 93% YoY; 2H PATMI recovered to S$10.8m.
FY2023 EBITDA was S$39.4m, down 51% YoY; 2H EBITDA was S$29.0m, down 32% YoY.
FY2023 gross profit was S$65.5m versus S$111.5m in FY2022; gross margin was 37.0% versus 46.9%.
2H2023 revenue was S$103.9m, down 18% YoY, as the 2H decline narrowed versus 1H.
Outlook and guidance
FY2024 performance is expected to deliver higher revenue and profits, contingent on no major unexpected events.
Consumer pipeline includes projects slated for mass production and new NPI-stage programs; a smartphone mass-production project began with a new leading consumer brand.
Industrial business is expected to remain stable in Singapore, China and Japan, with growth prospects from European expansion.
Sydrogen BPP coatings production is accelerating for automotive customers.
Latest events from Nanofilm Technologies
- Capacity investments and segment momentum underpin growth plans amid supply-chain disruption.MZH
Q4 2021 TU - Record FY2021 results and expanded capacity set the stage for FY2022 growth.MZH
H2 2021 - Revenue grew 24.2%, while startup and NPI costs pressured profit and margins.MZH
H1 2021 - Headwinds cut FY2022 results, while expansion and the 2025 targets remained on track.MZH
H2 2022 - Revenue fell 34.4% as consumer weakness drove a H1 loss; 2H revenue is expected higher.MZH
H1 2023 - FY2025 revenue rose 20% and PAT 58%, led by AMBU growth and an IEBU recovery.MZH
H2 2025 - Revenue rose 29.6% as PATMI returned to profit and adjusted EBITDA grew 46.1%.MZH
H1 2025 - Revenue grew 13%, adjusted EBITDA rose 61.4%, and FY2024 growth is expected.MZH
H1 2024 - Revenue rose 15% and adjusted EBITDA 31%, supported by growth and global expansion.MZH
H2 2024